Bunch, Connor M.Zackariya, NuhaThomas, Anthony V.Langford, Jack H.Aboukhaled, MichaelThomas, Samuel J.Ansari, AidaPatel, Shivani S.Buckner, HallieMiller, Joseph B.Annis, Christy L.Quate-Operacz, Margaret A.Schmitz, Leslie A.Pulvirenti, Joseph J.Konopinski, Jonathan C.Kelley, Kathleen M.Hassna, SamerNelligan, Luke G.Walsh, Mark M.2023-10-102023-10-102022-12-27Bunch CM, Zackariya N, Thomas AV, et al. COVID-associated non-vasculitic thrombotic retiform purpura of the face and extremities: A case report. Clin Case Rep. 2022;10(12):e6790. Published 2022 Dec 27. doi:10.1002/ccr3.6790https://hdl.handle.net/1805/36231SARS-CoV-2 infection can manifest many rashes. However, thrombotic retiform purpura rarely occurs during COVID-19 illness. Aggressive anti-COVID-19 therapy with a high-dose steroid regimen led to rapid recovery. This immunothrombotic phenomenon likely represents a poor type 1 interferon response and complement activation on the endothelial surface in response to acute infection.en-USAttribution-NonCommercial 4.0 InternationalCOVID‐19SARS‐CoV‐2Acral lesionsChilblainsExanthemaPurpuraVasculitisArticle